CRYSTAL STRUCTURE OF 3-BROMOPYRUVATE MODIFIED ISOCITRATE LYASE (ICL) FROM MYCOBACTERIUM TUBERCULOSIS

TB Structural Genomics Consortium (TBSGC)

Structure of isocitrate lyase, a persistence factor of Mycobacterium tuberculosis.

MASVVGTPKSAEQIQQEWDTNPRWKDVTRTYSAEDVVALQGSVVEEHTLARRGAEVLWEQLHDLEWVNALGALTGNMAVQ
QVRAGLKAIYLSGWQVAGDANLSGHTYPDQSLYPANSVPQVVRRINNALQRADQIAKIEGDTSVENWLAPIVADGEAGFG
GALNVYELQKALIAAGVAGSHWEDQLASEKKCGHLGGKVLIPTQQHIRTLTSARLAADVADVPTVVIARTDAEAATLITS
DVDERDQPFITGERTREGFYRTKNGIEPCIARAKAYAPFADLIWMETGTPDLEAARQFSEAVKAEYPDQMLAYNCSPSFN
WKKHLDDATIAKFQKELAAMGFKFQFITLAGFHALNYSMFDLAYGYAQNQMSAYVELQEREFAAEERGYTATKHQREVGA
GYFDRIATTVDPNSSTTALTGSTEEGQFH

PEG4000, sodium acetate, magnesium acetate, 3-bromopyruvate, pH 8.0, Microbactch under paraffin oil, temperature 289.0K

Structure of ICL with 3-nitropropionate and glyoxylate

Alpha-beta barrel, Helix-swapping, closed conformation, bromopyuvate modification, Structural Genomics, PSI, Protein Structure Initiative, TB Structural Genomics Consortium, TBSGC, LYASE